← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 1997Last known activity
Feb 1, 2016
Acquired by Orgenesis on Apr 13, 2020
Timeline
1980s
- Jun 1, 1981
Tamir Biotechnology, Inc.— Founded
2020s
- Apr 13, 2020
Orgenesis— Acquired By
Drugs by trial phase (2 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT02535104Lead sponsorPhase 1/Phase 2Feb 1, 2016
- NCT01184287Lead sponsorPhase 2Aug 17, 2010
- NCT00003034Study chairPhase 3May 1, 1997
- NCT00003034Lead sponsorPhase 3May 1, 1997
Details
- Founded
- Monmouth Junction, NJ, US Jun 1, 1981
- Last known activity
- Feb 1, 2016
